Leanbio is a market oriented CDMO that develops and manufactures biopharmaceutical products as New biological entities and Biosimilars, applying “Lean bioproduction” through tailored quality by design and ICH compliant approach in order to maximize project success, minimize time to market, costs and risks. 

Leanbio follows a knowledge-based strategy, applying cutting edge technological platforms and working altogether with customers through the different stages of development across project lifecycle: 
        
        Platform development
        Specific development
        Process characterization
        Scale-up
        Manufacture

Leanbio covers full value chain of services in the development and manufacture of biotherapeutics from gene to vial.


Biotechnology

Health Care

Pharmaceutical

Therapeutics

Leanbio

Dr. Andreu Soldevila

Laia Huerga Vallès

Carla Prat Llenas

Laura de la Torre Fuchs

Emilio Sánchez Pérez

Jaume Correa Cantón

Evan Gilman-Burke

Leticia Romero Pérez

Jordi Sarrà Herrera

This department oversees the strategic direction and overall management of the organization.

Executive Leadership

This department focuses on the research and development of processes to improve efficiency and effectiveness in production.

Process Development

This department ensures compliance with regulatory standards and oversees the quality control processes in production.

Quality Assurance

This department focuses on the research and development of digital signal processing technologies.

DSP Development

This department focuses on the scientific aspects and processes involved in manufacturing activities.

Manufacturing Science

This department oversees the planning, execution, and completion of projects, ensuring they are delivered on time and within budget.

Leanbio

Org chart

Teams

Executive Leadership

Process Development

Quality Assurance

DSP Development

Manufacturing Science

Project Management

Offices